Focus: Expedition Medicines is an early-stage biotech company specializing in generative design of small molecules for infectious diseases, gastroenterology, and neurology. Based in Cambridge, MA, they are a pre-revenue platform company leveraging computational approaches to drug discovery.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
0 added, 3 removed. Backfill posture.
Best suited for early-career or mission-driven scientists willing to accept pre-clinical stage risk for platform-building opportunity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Expedition Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Expedition Medicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo